Surface-exposed CRT binds DC-expressed CD91 (LRP1) [147], enhancing DC phagocytosis of dying tumor cells and cross-presentation of TAAs to CD8+ T cells, activating tumor-specific CTLs (Fig. 4a) [49]. Here, CALR is linked to neoplasm.